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Gram-negative bacteria use the Type VI secretion system (T6SS)
to inject toxic proteins into rival bacteria or eukaryotic cells.
However, the mechanism of the T6SS is incompletely understood.
In the present study, we investigated a conserved component
of the T6SS, TssK, using the antibacterial T6SS of Serratia
marcescens as a model system. TssK was confirmed to be
essential for effector secretion by the T6SS. The native protein,
although not an integral membrane protein, appeared to localize
to the inner membrane, consistent with its presence within a
membrane-anchored assembly. Recombinant TssK purified from
S. marcescens was found to exist in several stable oligomeric
forms, namely trimer, hexamer and higher-order species. Native-
level purification of TssK identified TssF and TssG as interacting
proteins. TssF and TssG, conserved T6SS components of
unknown function, were required for T6SS activity, but not for
correct localization of TssK. A complex containing TssK, TssF
and TssG was subsequently purified in vitro, confirming that these
three proteins form a new subcomplex within the T6SS. Our
findings provide new insight into the T6SS assembly, allowing
us to propose a model whereby TssK recruits TssFG into the
membrane-associated T6SS complex and different oligomeric
states of TssK may contribute to the dynamic mechanism of the
system.
Key words: bacterial protein secretion, native complex isolation,
protein oligomerization, Serratia marcescens, Type VI secretion
system (T6SS).
INTRODUCTION
Protein secretion by Gram-negative bacteria is the controlled
transport of selected proteins from the cytoplasm, across the cell
envelope and out of the cell. The secreted proteins may be released
into the extracellular environment or injected directly into target
cells. Protein secretion is performed by six classes of specialized
proteinaceous machinery, the Type I–Type VI secretion systems
(T1SS–T6SS) [1]. Secreted proteins enable bacteria to interact
closely with their surroundings, with eukaryotic host organisms
and with other bacteria, and they play a central role in bacterial
virulence [2]. T6SSs are the most recently described of the Gram-
negative bacterial secretion systems and are widely distributed
among diverse species. The T6SS has been shown to play an
important role in pathogenicity towards eukaryotic host cells in
a variety of important human pathogens, including Pseudomonas
aeruginosa, Burkholderia mallei, Vibrio cholerae and Aeromonas
hydrophila [3–8]. Most notably, the action of several of these anti-
eukaryotic systems appears to result in disruption of the actin
cytoskeleton [8,9]. It is now clear that the T6SS can be also
used to target other, competitor, bacteria and is thus likely to
play an important role in polymicrobial infections. Antibacterial
activity has been reported for T6SSs of multiple bacterial
species, including P. aeruginosa, V. cholerae and Burkholderia
thailandensis [10–12]. Various Type VI-secreted antibacterial
toxins have recently been identified. The biggest group are
peptidoglycan hydrolase enzymes which attack the cell wall
of target bacteria, including several families of peptidoglycan
amidase and glycoside hydrolase enzymes [13,14]. Additionally,
a superfamily of phospholipase effectors, attacking the target
cell membrane, were described recently and a small number
of other, unrelated, effector toxins have been experimentally
identified, but are yet to be fully characterized [13,15–17].
We reported previously that the opportunistic pathogen Serratia
marcescens Db10 possesses a single T6SS with potent strain-
specific antibacterial activity [18]. We have shown recently that
this antibacterial activity is provided, at least in part, by six
T6SS-dependent secreted effector proteins, Ssp1–Ssp6, all toxins
inhibitory to other bacterial strains [15,19]. S. marcescens avoids
self-killing by the production of cognate immunity proteins
which provide specific protection against the toxicity of the
different effectors. For example, Ssp1 and Ssp2 are peptidoglycan
amidase enzymes whose activity is specifically inhibited by high-
affinity binding of the immunity proteins Rap1a and Rap2a
respectively, forming heterotetrameric complexes in which the
effector active site is blocked by the immunity protein [19,20].
Since S. marcescens possesses a single constitutively active T6SS,
it provides a convenient system to study the basic mechanism of
this important secretion system.
T6SSs contain 13 conserved components (TssA–TssM) which
are thought to form the core apparatus and to enable effector
proteins to be injected into target cells in a single cell-contact-
dependent step [21–23]. Various biochemical and structural
data support a model in which T6SS components form
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several subassemblies that interact to form a dynamic inverted
bacteriophage-like injection machine. The first is a membrane-
associated complex that transverses the periplasm and anchors
the T6SS in the cell envelope. This subassembly is composed of
two integral membrane proteins, TssL and TssM, and an outer
membrane periplasmic-facing lipoprotein, TssJ, where TssM
interacts with TssL and TssJ, through its large periplasmic C-
terminal domain, to form a membrane-spanning channel [24–27].
The cytoplasmic domain of TssM has been shown to display
ATPase activity and is thought to play an energizing role in
the system [28]. The T6SS is anchored to the cell wall by
TssL either through its own periplasmic peptidoglycan-binding
domain or through its interaction with the TagL accessory protein
[29,30]. The second subassembly is a bacteriophage-like structure
containing the extracellular components Hcp (TssD) and VgrG
(TssI), which are structurally related to bacteriophage T4 tube
and tailspike proteins respectively. Hcp proteins form hexameric
ring-shaped structures that can polymerize and assemble as
tube-like structures, and a trimer of VgrG is believed to cap
the top of the Hcp tube and puncture target cell membranes
[31–34]. It has been proposed recently that small PAAR (Pro-
Ala-Ala-Arg) domain proteins may form the final sharp tip of
the needle [35]. This ‘needle’ is thought to be surrounded by
a tubular complex composed of TssB (VipA) and TssC (VipB),
forming an intracellular contractile phage sheath-like structure
[36–38]. Extended and contracted conformations of this tubule
structure have been observed by microscopy, and contraction
is thought to eject the Hcp–VgrG structure out of the secreting
cell and into a target cell, thereby allowing the translocation of
effector molecules [36]. Additionally, this tubular structure was
observed to be connected to the inner membrane by a cytoplasmic
bell-shaped ‘basal’ structure that is yet to be characterized
[36]. Contracted TssBC tubular complexes are recognized and
disassembled by the AAA + (ATPase associated with diverse
cellular activities) protein TssH (ClpV) that has also been shown
to remodel these complexes in vitro in the presence of ATP. This
remodelling activity should allow recycling of the apparatus for
new rounds of secretion and also reverse non-productive sheath
formation in the cytoplasm [38,39].
Considering the five remaining core T6SS components, TssE
has detectable similarity with the phage gp25 baseplate protein
[40], but no function has been readily assigned to the other
proteins (TssA, TssF, TssG and TssK). It is thought that these
five proteins may be located in the cytoplasm and form part
of the basal structure that can be observed by microscopy. The
TssK protein has been shown previously to be essential for T6SS
activity in systematic mutagenesis studies in Edwardsiella tarda,
V. cholerae and Agrobacterium tumefaciens [41,42]. In addition, a
recent study has confirmed that TssK is required for T6SS activity
in EAEC (enteroaggregative Escherichia coli) and suggested that
it interacts with several components of the membrane complex
and phage-like subassemblies [43].
The aim of the present study was to investigate the biochemical
properties, cellular localization and interaction partners of the
TssK protein of the S. marcescens T6SS. We aimed to study TssK,
as far as possible, at native levels and in the native organism,
in particular to obtain physiologically relevant localization and
interaction data. We demonstrate that TssK is essential for T6SS
activity and exhibits several stable oligomeric states. Additionally,
analysis of the native protein is used to show that TssK localizes
with the inner membrane, apparently as part of a stable T6SS
assembly, and to identify TssF and TssG as interaction partners of
TssK. Finally, a stable complex containing TssF, TssG and TssK
can be isolated in vitro and may represent a new subcomplex
within the basal structure of the T6SS.
EXPERIMENTAL
Bacterial strains, culture conditions and plasmids
Bacterial strains and plasmids used in the present study are
detailed in Table 1. S. marcescens was routinely grown with good
aeration in LB medium (10 g/l tryptone, 5 g/l yeast extract and
5 g/l NaCl) at 30 ◦C. When required, media were supplemented
with antibiotics: ampicillin (100 μg/ml), kanamycin (100 μg/ml)
and chloramphenicol (25 μg/ml). S. marcescens chromosomal
mutants with in-frame deletions in selected genes or introducing
a chromosomal His6 tag fused at the N-terminus or C-
terminus of tssK (SMA2253) were constructed by marker (allelic)
exchange using the suicide vector pKNG101 [44] as described
previously [18]. Plasmids for complementing the expression
of the deleted gene in trans were derived from pSUPROM
or pSC100. For protein overexpression and purification, tssK
with a C-terminal TEV (tobacco etch virus) protease-cleavable
His6 tag was cloned in pSC102. For co-purification of the
TssKFG complex, tssF with an N-terminal TEV protease-
cleavable His6 tag and untagged tssG were cloned in site 1
of pACYCDuet-1 (NcoI/BamHI, BamHI/EcoRI), and untagged
tssK was cloned in site 2 (NdeI/XhoI). Molecular biological
techniques were performed according to standard protocols [45]
and manufacturers’ instructions. Oligonucleotide primers were
obtained from Sigma–Genosys, molecular biology reagents were
purchased from leading suppliers (Roche, NEB, Invitrogen and
Sigma) and synthetic DNA sequences used in the construction of
pSC168 were generated by Dundee Cell Products.
Immunodetection of proteins
For detection of secreted proteins, anti-Hcp immunoblots were
performed as described in [18] and anti-Ssp2 immunoblots
were carried out as described in [19]. Anti-TssK rabbit polyclonal
antibody was raised against the purified protein (Dundee Cell
Products) and used at 1:1000 dilution, and anti-TssJ antibody [27]
was used at 1:4000 dilution, both using horseradish-peroxidase-
conjugated goat anti-rabbit secondary antibody (Thermo Fisher
Scientific) at 1:10000 dilution. Anti-RNAPβ (RNA polymerase β)
antibody (Neoclone) was used at 1:20000 dilution, and anti-MBP
(maltose-binding protein) antibody (NEB) was used at 1:10000
dilution; both with horseradish-peroxidase-conjugated goat anti-
mouse secondary antibody (Roche) at 1:10000 dilution.
Fractionation to determine native localization of TssK
Bacterial strains were grown at 30 ◦C for 5 h. The cells from 5 ml
of culture were incubated with 0.5 ml of 0.5 M Tris/HCl (pH 7.8)
for 10 min at room temperature, then harvested by centrifugation
at 2773 g for 10 min at 4 ◦C. Cell pellets were washed once with
5 ml of LB buffer then resuspended in 1 ml of ice-cold osmotic
shock buffer [30 mM Tris/HCl, pH 7.8, 40% (w/v) sucrose
and 2 mM EDTA]. This represented the whole-cell fraction.
After 10 min of incubation at 30 ◦C, pellets were collected
by centrifugation at 14100 g for 10 min at 4 ◦C, resuspended
quickly with 900 μl of ice-cold MilliQ water and kept on ice
for 10 min. The supernatant collected after centrifugation at
14100 g for 10 min at 4 ◦C contained the periplasmic fraction
and the pellet was resuspended in 900 μl of 50 mM Tris/HCl
(pH 7.8) for sonication. Samples were lysed on ice by sonication
for five 15 s bursts (25% amplitude) at 30 s intervals, and the
unbroken cells and cellular debris were removed by centrifugation
at 14100 g for 5 min at 4 ◦C. The supernatant was recovered
and represented the crude cell extract. The extract (750 μl)
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Table 1 Bacterial strains and plasmids used in the present study
Ap, ampicillin; Cm, chloramphenicol; Kn, kanamycin; Sm, streptomycin.
Strain or plasmid Genotype or relevant features Source or reference
Strains
Serratia marcescens Db10 Wild-type strain Laboratory stock
SJC3 Db10 clpV (SMA2274, TssH) [18]
SJC10 Db10 lip (SMA2252, TssJ) [18]
SJC11 Db10 tssE (SMA2271, TssE) [18]
MJF1 Db10 tssK –His6 (SMA2253 with a C-terminal His6 tag) The present study
SJC23 Db10 His6–tssK (SMA2253 with an N-terminal His6 tag) The present study
GE04 Db10 tssK (SMA2253) The present study
GE05 MJF1 tssG (SMA2273) The present study
GE06 MJF1 tssF (SMA2272) The present study
Plasmids
pSUPROM Plasmid for constitutive expression of cloned genes under the control of the E. coli tat promoter, KnR [56]
pACYCDuet-1 Protein coexpression plasmid containing two cloning sites, each preceded by an IPTG-inducible T7 promoter, CmR Novagen
pSC045 tssE (SMA2271) coding sequence in pSUPROM, KnR [18]
pSC100 Medium-copy protein-overexpression plasmid derived from pQE80, IPTG-inducible T5 promoter, permits fusion of
His6 tag to the N- or C-terminus of the overexpressed protein, ApR, KnR
The present study
pSC102 Medium-copy protein-overexpression plasmid derived from pQE80, IPTG-inducible T5 promoter, permits fusion of a
His6 tag followed by a TEV protease cleavage site to the N- or C-terminus of the overexpressed protein, ApR, KnR
The present study
pSC119 tssK (SMA2253) coding sequence in pSC102, generating a fusion protein with a TEV-cleavable C-terminal His6 tag,
ApR, KnR
The present study
pSC132 Marker exchange plasmid for generation of chromosomal tssK –His6 fusion, in pKNG101, SmR The present study
pSC167 tssG (SMA2273) and tssK (SMA2253) coding sequences in pACYCDuet-1 (in sites 1 and 2 respectively), directing
expression of untagged TssG and TssK (precursor of pSC168)
The present study
pSC168 tssF (SMA2272), tssG (SMA2273) and tssK (SMA2253) coding sequences in pACYCDuet-1 (tssF and G in site 1, tssK
in site 2), directing expression of TssG and TssK without any tags and TssF fused to an N-terminal His6 tag followed
by a TEV protease cleavage site
The present study
pSC521 tssK (SMA2253) coding sequence in pSC100, generating a fusion protein with a C-terminal His6 tag, ApR, KnR The present study
pSC522 tssK (SMA2253) coding in pSC100, generating a fusion protein with an N-terminal His6 tag, ApR, KnR The present study
pSC532 Marker exchange plasmid for generation of in-frame deletion of tssK , in pKNG101, SmR The present study
pSC554 Marker exchange plasmid for generation of in-frame deletion of tssF , in pKNG101, SmR The present study
pSC555 Marker exchange plasmid for generation of in-frame deletion of tssG, in pKNG101, SmR The present study
pKNG101 Suicide plasmid for marker exchange, sacBR, mobRK2, oriR6K, SmR [44]
pBluescript KS + High-copy-number cloning plasmid, multiple cloning site in lacZ ’, ApR Stratagene
was treated with urea or carbonate to release proteins loosely
or non-specifically associated with the membranes, followed
by an ultracentrifugation step at 200000 g for 30 min at 4 ◦C.
The supernatant was recovered and represented the soluble
cytoplasmic fraction. The remaining pellet, containing inner and
outer membranes, was resuspended in 750 μl of 50 mM Tris/HCl
(pH 7.8) and represented the total membrane fraction. A 100 μl
sample of each cellular fraction was mixed with 100 μl of 2×
gel sample buffer [18] and analysed by SDS/PAGE (15% gel)
and immunoblotting. Equivalent amounts, on an individual cell
basis, of each fraction in each strain were assayed. Custom anti-
TssK polyclonal antibody was used to detect TssK, anti-RNAPβ
antibody was used as the cytoplasmic marker, anti-MBP antibody
was used as the periplasmic marker and anti-TssJ antibody was
used as the membrane marker, as above.
To examine the nature of membrane association, total
membranes (prepared without prior treatment of the crude cell
extract) were incubated with 50 mM Tris/HCl (pH 7.8) containing
6 M urea, 1 M NaCl or 0.2 M Na2CO3 for 1 h at room temperature
and were then subjected to another ultracentrifugation step.
Alternatively, membranes were solubilized with 50 mM Tris/HCl
(pH 7.8) containing 2% (w/v) DDM (dodecyl maltoside), 2%
(w/v) CHAPS or 2% (v/v) Triton X-100 detergents and, following
incubation for 2 h at 4 ◦C, solubilized membrane proteins
were separated from insoluble proteins by ultracentrifugation at
200000 g for 30 min at 4 ◦C.
Inner and outer bacterial membranes were separated using
discontinuous sedimentation sucrose gradients based on the
method described in [24,46]. Wild-type S. marcescens total
membranes were prepared from 500 ml of culture and
resuspended in 0.5 ml of 20% (w/v) sucrose containing a
1:200 dilution of EDTA-free protease inhibitor cocktail set III
(Calbiochem). The membrane fraction was then loaded on to the
top of a discontinuous sucrose gradient composed of nine 1.2 ml
layers of sucrose (from top to bottom), i.e. 30%, 35%, 37.5%,
40%, 42.5%, 45%, 50%, 55% and 70%, and subjected to
ultracentrifugation at 100000 g for 70 h at 4 ◦C in a SW 41 Ti
rotor (Beckman). Fractions of 0.5 ml were collected from the top
and every second fraction was analysed by SDS/PAGE (15% gel)
and immunoblotting using anti-TssK and anti-TssJ antibodies.
Protein overexpression and purification
Recombinant TssK protein was produced in S. marcescens Db10
freshly transformed with plasmid pSC119. Transformant colonies
were used to inoculate 5 ml of LB medium with kanamycin
and grown overnight at 30 ◦C. From this, 2.5 ml was used to
inoculate 500 ml of LB medium supplemented with kanamycin
and IPTG at a final concentration of 1 mM in 2.5 ml baffled
flasks and grown at 30 ◦C with good aeration for 8 h. Cells
were harvested by centrifugation at 4000 g for 45 min at 4 ◦C,
washed with 20 ml of 50 mM Tris/HCl (pH 7.5) and stored at
− 80 ◦C. The thawed cell pellet was resuspended in lysis buffer
(50 mM Tris/HCl, pH 7.5, containing a 1:200 dilution of EDTA-
free protease inhibitor cocktail set III; 4 ml/g of cell pellet)
c© 2014 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which
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and incubated at room temperature for 15 min. The cells were
transferred to a glass tissue homogenizer and ground slowly on
ice to avoid foam formation. The cells were then lysed with four
passes through an Emulsiflex French press-style high pressure
cell disruptor [20000 psi (1 psi = 6.9 kPa)] and cell debris
was removed by centrifugation at 14100 g for 30 min at 4 ◦C.
TssK–His6 was initially isolated by IMAC (immobilized metal-
ion-affinity chromatography). The supernatant (soluble protein
fraction) was loaded on to a 5 ml HisTrapTM HP chelating column
(GE Healthcare) pre-loaded with Ni2 + at a flow rate of 1 ml/min
using the ¨AKTApurifierTM FPLCTM system (GE Healthcare) at
4 ◦C. The HisTrapTM HP affinity column had been equilibrated
previously with IMAC binding buffer A (50 mM Tris/HCl, pH 7.5,
250 mM NaCl and 25 mM imidazole). After loading the cell
lysate, the HisTrapTM HP affinity column was washed with
IMAC binding buffer A until a constant A280 was observed. His6-
tagged TssK was eluted using a linear concentration gradient
of 0–500 mM imidazole in IMAC elution buffer B (50 mM
Tris/HCl, pH 7.5, 250 mM NaCl and 500 mM imidazole) over
12 column volumes. The eluate was collected in 1 ml fractions
and analysed by Coomassie Blue-stained SDS/PAGE, and TssK-
containing fractions were pooled and stored at 4 ◦C. To remove
the His6 tag, the pooled fractions were incubated with His6-
tagged TEV protease at room temperature while dialysing against
IMAC binding buffer A for 1 h then incubated at 30 ◦C for
3 h. The sample was reapplied to the HisTrapTM HP affinity
column and eluted as described above to separate the untagged
protein (present in the flowthrough) from any residual His6-tagged
recombinant protein, His6 tag and the His6-tagged TEV protease.
Fractions were analysed by SDS/PAGE (15% gel) and those
containing the untagged recombinant protein were pooled and
stored at 4 ◦C. The protein was purified further by SEC (size-
exclusion chromatography) using a pre-packed Superdex 200
26/600 (GE Healthcare) previously equilibrated with gel filtration
buffer (50 mM Tris/HCl, pH 7.5, and 250 mM NaCl). The pooled
protein fractions were concentrated to 0.5 ml using an appropriate
molecular-mass cut-off spin concentrator (Millipore) and applied
to the SEC column using a 1 ml sample loop. Fractions of 0.5 ml
were collected at a flow rate of 0.5 ml/min, and the level of
sample purity in each fraction was determined by SDS/PAGE
(15% gel). Columns were calibrated previously with high-
and low-molecular-mass standards: Blue Dextran (>2000 kDa),
thyroglobulin (669 kDa), ferritin (440 kDa), aldolase (158 kDa),
conalbumin (75 kDa), ovalbumin (43 kDa), carbonic anhydrase
(29.5 kDa), RNase A (13.7 kDa) and aprotinin (6.5 kDa) (GE
Healthcare).
For co-purification of TssK–TssF–TssG, His6–TssF, TssG and
TssK were co-produced in E. coli BL21(DE3) cells from pSC168
and the complex was purified using protocols described previously
[19] and similar to above. In brief, following overproduction, the
complex was isolated by an initial IMAC step, then the His6 tag
on TssF was cleaved, followed by a negative IMAC step and
finally two rounds of SEC using a calibrated Superose 6 10/300
GL column (GE Healthcare). Quantitative in-gel SYPRO Orange
staining was performed as described in [47], with image analysis
using ImageJ (NIH). Molar ratios resulted from the mean of at
least four quantifications.
Negative-staining electron microscopy
Immediately after gel filtration, purified TssK was diluted to
0.1 mg/ml in 50 mM Tris/HCl (pH 7.5) and 250 mM NaCl,
collected on carbon film on mica and stained with 0.05 M
uranyl acetate in 0.05 M HCl. The film was collected on an
uncoated mesh copper grid, blotted dry and viewed in a Jeol
1200EX transmission electron microscope. Images were captured
on Ditabis Micron imaging plates (Digital Biomedical Imaging
Systems), scanned at 6000 × 5000 0.15 μm pixels and assembled
into Figures using Adobe Photoshop.
Analytical ultracentrifugation
The oligomeric state of pooled fractions of TssK from within
Peak 1 and Peak 2 was ascertained via AUC (analytical
ultracentrifugation) experiments performed at 4 ◦C using an
Optima XL-I analytical ultracentrifuge (Beckman Coulter) and
an An-50 Ti eight-hole rotor. Samples were loaded into 12 mm
pathlength charcoal-filled epon double-sector centrepieces, with
50 mM Tris/HCl (pH 7.5) and 250 mM NaCl buffer as reference
solvent. SV (sedimentation velocity) was measured for samples
(360 μl) at concentrations from 0.2 to 0.7 mg/ml (for Peak 1) and
0.2 and 0.5 mg/ml (for Peak 2). A series of sedimentation traces
was collected every 7 min at a rotor speed of 49000 rev./min
using interference optics and absorbance optics. Data were
recorded over the radial range 6.0–7.25 cm, and a radial step
size of 0.005 cm was used in the acquisition of absorbance
data. In order to optimize the quality of the interference data,
the laser delay and other related settings were adjusted before
data acquisition. Data were analysed using the program SEDFIT
[48]. Of the 64 sedimentation traces acquired, only 35 were
used in the analysis, since the sample had reached the cell
base by trace 35. Sedimentation boundaries were modelled as
numerical finite element solutions of the Lamm equation using
c(s) analysis. Apparent weight average sedimentation coefficients
for Peak 1 were obtained by integrating over the peaks in the c(s)
distributions. The partial specific volume v¯ of TssK calculated
from its amino acid composition using the program SEDNTERP
[49] was 0.737 ml/g at 20 ◦C and 0.730 ml/g at 4 ◦C. SEDNTERP
was also used to calculate the density and viscosity of the buffer
at 20 ◦C and 4 ◦C (1.00994 and 1.01173 g/ml, and 0.01040 and
0.01627 P respectively). As both SV absorbance and interference
data yielded the same results, only absorbance data have been
presented. SE (sedimentation equilibrium) was undertaken for
samples (90 μl) at concentrations from 0.2 to 1.1 mg/ml. The
distribution of TssK was monitored by interference optics
at 3-h intervals at a rotor speed of 9000 rev./min until the
system had reached equilibrium. This was ascertained using the
program WinMATCH (Jeffrey Lary, University of Connecticut,
Storrs, CT, U.S.A.) and equilibrium distributions at each loading
concentration were analysed with the program SEDPHAT [50].
Affinity purification of chromosomal His6-tagged TssK protein
S. marcescens strains were grown at 30 ◦C for 5 h in 500 ml of
LB medium. Cells were harvested by centrifugation at 3500 g
for 45 min at 4 ◦C, washed once with 10 ml of 50 mM Tris/HCl
(pH 7.5), then snap-frozen in liquid nitrogen. The thawed cell
pellet was resuspended in resuspension buffer (50 mM Tris/HCl,
pH 7.5, 250 mM NaCl, 25 mM imidazole, 1:200 dilution of
EDTA-free protease inhibitor cocktail set III and a few crystals
of DNase I and lysozyme; 5 ml/g of cell pellet) and the cells
were lysed with four passes through an Emulsiflex French press-
style high pressure cell disruptor (20000 psi; Avestin). Cell debris
was removed by centrifugation at 14100 g for 30 min at 4 ◦C
and the supernatant was retained for further ultracentrifugation
at 100000 g for 1.5 h at 4 ◦C. The supernatant was discarded
and the remaining pellet, containing inner and outer membranes,
was resuspended in 0.5 ml of 20% (w/v) sucrose (in 50 mM
c© 2014 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which
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Tris/HCl buffer containing a 1:200 dilution of EDTA-free protease
inhibitor cocktail set III) and gently homogenized on ice to avoid
foaming. The homogenized total membrane fraction was then
applied to a discontinuous sucrose gradient to separate inner
and outer membranes, as above. Inner membrane-containing
fractions were pooled and Triton X-100 was added dropwise to
a final concentration of 2% (v/v), then samples were incubated
for 2 h at 4 ◦C and kept on ice until required. To prepare the
magnetic Ni-NTA (Ni2 + -nitrilotriacetate) beads (Qiagen) for
affinity purification, 60 μl of magnetic beads were washed twice
with 1 ml of wash buffer (20 mM Tris/HCl, pH 7.5, 100 mM
NaCl, 25 mM imidazole and 0.1% Triton X-100). The inner
membrane sample was added to the pre-washed magnetic beads
and incubated for 2 h at 4 ◦C with gentle end-over-end mixing to
allow the binding of the TssK–His6 protein (and any interacting
binding partners) to the Ni2 + -charged beads. The magnetic beads
were then washed thoroughly six times with 1 ml of wash buffer
and the bound proteins were eluted by addition of 20 μl of 2× gel
sample buffer and boiling for 2 min. Eluted proteins were resolved
and analysed by SDS/PAGE (15% gel) and colloidal Coomassie
Blue staining. Protein bands of interest were excised from the
SDS/PAGE gel and subjected to in-gel trypsin digestion followed
by one-dimensional nano-LC–ESI–MS/MS using a 4000 QTrap
(Applied Biosystems) tandem-MS system by the FingerPrints
Proteomics Facility, College of Life Sciences, University of
Dundee. Raw QTrap data was analysed using MASCOT software
for protein identification.
RESULTS
TssK is essential for T6SS activity in S. marcescens
A gene (SMA2253) encoding a 488-amino-acid homologue of the
core component TssK is located within the S. marcescens Db10
T6SS gene cluster [18]. In order to determine the requirement
of TssK for the basic function of the T6SS in S. marcescens,
an in-frame chromosomal deletion of tssK was constructed. The
ability of this mutant to secrete Hcp1 and the effector protein
Ssp2, known substrates of the system [18,19], to the culture
supernatant was determined by immunoblotting. For controls,
culture supernatant from the wild-type strain and an inactive
T6SS mutant lacking an essential component, tssE, was also
probed. As shown in Figure 1, deletion of tssK abolished secretion
of both Hcp1 and Ssp2. This secretion defect could be fully
complemented by the expression of N-terminal and C-terminal
His6-tagged versions of the missing gene in trans, confirming the
essential contribution that this component makes to T6SS function
in this organism.
Native TssK localizes to the inner membrane despite not being an
integral membrane protein
In order to determine the subcellular localization of the native
TssK protein in wild-type S. marcescens, an anti-TssK polyclonal
antibody was utilized to probe TssK in each of the major cellular
fractions. As shown in Figure 2(A), native TssK was found to
localize exclusively in the membrane-containing fraction in the
wild-type strain. This was unexpected as no part of the TssK
protein is predicted to form classic hydrophobic transmembrane
helices or amphipathic α-helical structures (results not shown).
Thus, to examine the nature of the apparent membrane association
of TssK, S. marcescens membranes were treated with various
agents to discriminate between peripheral and integral membrane
associations. The outer membrane lipoprotein TssJ [24] was
Figure 1 TssK is required for Type VI secretion by S. marcescens
Anti-Hcp1 immunoblot of cellular and secreted proteins and anti-Ssp2 immunoblot of secreted
proteins from wild-type S. marcescens Db10 (WT), T6SS mutants (SJC11, tssE ; GE04,
tssK ) and T6SS mutants carrying either vector control plasmids (tssE + Vector, pSUPROM;
tssK + Vector, pSC100) or complementing plasmids (tssE + pTssE, pSC045; tssK
+ pTssK-C, pSC521; tssK + pTssK-N, pSC522). The volume of sample loaded in each lane
for a given antibody corresponds to the same number of cells. Molecular masses are indicated
in kDa.
used as a membrane-bound control. As shown in Figure 2(B),
TssK and TssJ were resistant to extraction by salt or alkali,
indicating that both proteins are not peripherally associated with
the membranes. Partial solubilization of TssK by 6 M urea is
consistent with presence of TssK in a stable membrane-bound
complex (see below). Next, S. marcescens membranes were
treated with the detergents DDM, CHAPS or Triton X-100 to
solubilize conventional integral membrane proteins. Following
treatment with the detergent and recentrifugation, TssJ was
solubilized and found in the supernatant, whereas TssK remained
in the pellet (Figure 2C). This result indicated that native TssK
could be part of a membrane-bound complex that is resistant to
detergent challenge or present in a complex or aggregate that
is large enough to be pelleted by ultracentrifugation. Therefore,
to determine further whether TssK was associated with the
inner membranes, the outer membranes or a particulate fraction,
discontinuous sucrose gradient centrifugation was employed to
separate inner membranes, outer membranes and any particulate
material (pellet). Using this method, bacterial inner membranes
migrate to a position within the upper part of the gradient and
outer membranes migrate within the lower part, in each case
producing a distinct visible band [24,46]. Following separation,
TssK was not detected at significant levels in the pellet or the
outer membrane fraction (which was clearly defined both visually
and using the outer membrane marker TssJ [24]). In contrast,
TssK comigrated with the visually observed inner membrane band
within the first half of the gradient (Figure 2D). Unfortunately,
no antisera able to detect a specific inner membrane protein in
this organism were available for direct comparison. Nevertheless,
taken together, our data indicate that native TssK is present within
an assembly localized to the inner membrane, presumably some
or all of the T6SS apparatus.
Finally, we determined that the subcellular localization of the
native TssK protein was unaffected in mutants carrying single in-
frame deletions of three essential T6SS structural genes, tssE, tssH
and tssJ (Figure 2A). TssJ is an outer membrane periplasm-facing
lipoprotein that forms, together with TssL and TssM, the T6SS
membrane complex [24,26], TssE may form part of a cytoplasmic
baseplate-like structure [40] and TssH is the AAA + protein
required for remodelling TssBC complexes [38,39].
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Figure 2 Subcellular localization of native TssK
(A) TssK localizes to the total membrane fraction. Cells of wild-type S. marcescens Db10 (WT) and T6SS mutants (GE04, tssK ; SJC11, tssE ; SJC3, tssH; SJC10, tssJ) were subjected
to fractionation as described in the Experimental section (WC, whole-cell extract; PP, periplasm; CYT, cytoplasm; MEM, membranes). Fractions were analysed by immunoblotting using antibodies
against TssK, MBP (periplasmic marker), RNAPβ (cytoplasmic marker) and TssJ (membrane marker) as indicated. All fractionation controls are included for the wild-type and tssK strains; for the
other mutants, controls behaved identically with those shown. The volume of sample loaded in each lane for a given antibody corresponds to the same number of cells. The predicted mass of TssK is
50.4 kDa. (B and C) TssK association with the membrane fraction is resistant to salt, carbonate and detergent treatment. Total membrane pellets of wild-type S. marcescens Db10 were incubated with
50 mM Tris/HCl (pH 7.8) containing 6 M urea, 1 M NaCl or 0.2 M Na2CO3 (B), or with 50 mM Tris/HCl (pH 7.8) containing 2 % (w/v) DDM, 2 % (w/v) CHAPS or 2 % (v/v) Triton X-100 detergents
(C), then separated by ultracentrifugation into pellet (P) and soluble (S) fractions and analysed by immunoblotting using anti-TssK or anti-TssJ antibodies as indicated. (D) TssK is localized in the
inner membrane. Inner and outer membranes of S. marcescens Db10 were separated by discontinuous sucrose gradient separation and fractions were analysed visually and by immunoblotting using
antibodies against TssK and TssJ (outer membrane marker). Molecular masses are indicated in kDa.
Recombinant TssK can exist in different oligomeric states in
solution
With the aim of performing biochemical analysis of the
protein, recombinant TssK was overexpressed and purified to
homogeneity from the native organism, wild-type S. marcescens
(Figure 3A). When subjected to SEC, two distinct peaks of size
and composition were separated. These were suggestive of tetra-
meric (∼200 kDa; ‘Peak 1’) and octameric assemblies of TssK
(∼400 kDa; ‘Peak 2’). An SDS-resistant higher-order form of
TssK with an apparent mass of ∼100 kDa was also observed
on analysis by SDS/PAGE. We wanted to investigate how stable
the Peak 1 and Peak 2 forms of this protein were. The fractions
corresponding to Peak 1 were pooled and subjected to a second
round of SEC. As shown in Figure 3(B), the Peak 1 state of
TssK was maintained and there was negligible detectable re-
equilibration to the Peak 2 form. This was repeated for Peak 2 and,
similarly, detectable re-equilibration to the Peak 1 form was not
observed. Additionally, a third peak was observed in the original
SEC chromatogram corresponding to the void volume fraction
(Figure 3A). Analysis of this fraction by negative-staining EM
unexpectedly revealed the presence of prominent high-molecular-
mass oligomeric structures with a consistent diameter and an
average length of 100–200 nm (Figure 3C).
In order to determine the oligomeric state of TssK in Peak 1
and Peak 2, fractions within each peak were pooled and analysed
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Figure 3 Recombinant TssK exists in different stable oligomeric states in solution
(A) SEC analysis of recombinant TssK using a calibrated Superdex 200 26/60 column. Two peaks at elution volumes apparently consistent with tetramer (∼200 kDa, Peak 1) and octamer (∼400 kDa,
Peak 2) forms were detected, in addition to a peak corresponding to the void volume of the column. Insets: analysis of peak fractions by SDS/PAGE and Coomassie Blue staining. The bands present at
∼50 and ∼100 kDa and identified as TssK by MS are indicated by arrowheads. (B) Further analysis of the fractions from Peak 1 and Peak 2 in (A). Fractions from each peak were pooled individually
and subjected to a second round of SEC using the same column. The original trace is shown on top (black line) and the re-injected trace is shown below for Peak 1 (bottom left, continuous grey
line) and Peak 2 (bottom right, broken grey line). The void volume is indicated. (C) Representative electron micrographs of the negatively stained TssK from the void volume fraction from (A). Scale
bar, 50 nm.
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Figure 4 Analysis of the oligomeric states of recombinant TssK by AUC
(A) Continuous distribution c(s) analysis of sedimentation velocity data for Peaks 1 and
2. The samples both contain two species with apparent sedimentation coefficients of 7.25
and 11.10 S. (B) Sedimentation equilibrium data for Peak 1 at a loading concentration
of 0.2 mg/ml fitted with a three-species model in which the masses of two species were
fixed at masses corresponding to trimeric and hexameric TssK and the third allowed to
vary. Residuals of the fit are shown below. Plots were rendered with the program GUSSI
(http://biophysics.swmed.edu/MBR/software.html).
by AUC (Figure 4). Using SV, TssK from Peak 1 or Peak 2
was found to comprise two species with apparent sedimentation
coefficients of 7.25 and 11.10 S at the concentrations analysed
(Figure 4A). A spherical molecule of mass corresponding to that
of a trimer of TssK with a plausible hydrodynamic hydration of
0.4 g of water/g of protein would have a sedimentation coefficient
of 8.5 S, whereas that of a spherical tetramer would be 10.4 S.
The non-spherical shape of a real protein complex will reduce
the sedimentation coefficient from that of a sphere, but probably
not by as much as 3 S since the SV data do not indicate the
hydrodynamic non-ideality that would result from such a level
of molecular asymmetry. So the experimentally determined value
of 7.25 S is highly suggestive of a trimer, rather than a tetramer.
The sedimentation coefficients computed for equivalent hydrated
spheres for a hexamer and an octamer are 13.5 and 16.4 S
respectively. Comparison with the experimental value (11.10 S)
is indicative of a hexamer, as opposed to an octamer.
SE was performed at a rotor speed suitable for observation
of species ranging in mass from a dimer to an octamer of
TssK. With the knowledge that two species were observed in
all samples by SV, the SE data were fitted to a two species
model, with masses corresponding to a trimer and a hexamer
of TssK. However, the fits were improved upon the addition of
a third, higher-molecular-mass, species (Figure 4B). The mass
of this species was not constant across the concentration range
for Peaks 1 and 2 (results not shown) and was in excess of the
upper limit properly observable at the rotor speed used (octamer).
Also, the proportion of the sample modelled by the different
species was significantly altered: for instance, the SV data for
Peak 1 at 0.2 mg/ml were fitted with 60% ‘trimer’ species and
40% ‘hexamer’ species, whereas the SE data were fitted with
20% ‘trimer’, 30% ‘hexamer’ and 50% ‘big-mer’. This higher-
molecular-mass species was absent from the SV data, although,
if present, it would have been observable at the rotor speed and
data acquisition time interval used. The SE data were acquired for
the TssK samples that had been studied by SV 24 h previously.
It is possible that we observed a very slow process of higher
oligomer formation, reflected in the third peak of the original
SEC chromatogram. Thus, in summary, the SE data are highly
suggestive of a system that contains slowly declining populations
of trimeric and hexameric species, at the cost of an evolving
proportion of larger complexes.
Isolation of a native TssK-containing complex: identification of TssF
and TssG as interaction partners of TssK
We hypothesized that TssK forms a complex with other T6SS
components, perhaps contributing to the basal structure of
the T6SS apparatus previously observed by microscopy [36].
We aimed to identify TssK-binding partners by isolating a
native TssK-containing complex under physiological conditions,
through affinity purification of TssK protein that was His6-
tagged at the normal chromosomal location in S. marcescens.
Strains bearing chromosomal His6 tag fusions to the N-terminus
or C-terminus of the TssK ORF were constructed. Anti-TssK
immunoblotting confirmed that TssK was expressed and stable
in both strains, at levels comparable with that of the wild-
type (Figure 5A). These strains were then tested to determine
whether their T6SS was functional, by monitoring their ability
to secrete Hcp1 and Ssp2. As shown in Figure 5(A), in the N-
terminal His6–TssK fusion strain, the T6SS was non-functional,
being unable to secrete Hcp1 or Ssp2. Thus modifying the N-
terminus of TssK impairs its function sufficiently to abrogate
T6SS function at native levels. However, the C-terminal fusion
strain TssK–His6 was functional for T6SS activity, being able
to secrete both Hcp and Ssp2 similarly to the wild-type strain.
Consistent with its proper activity, the subcellular localization of
TssK was also unaffected by the presence of the C-terminal His6
tag (Figure 5B). Thus this strain was used for downstream affinity
purifications. Magnetic Ni2 + -coupled matrix was used to affinity
purify TssK–His6, together with any interacting protein partners,
from inner membrane fractions prepared from the S. marcescens
chromosomal tssK–His6 strain. Eluted proteins were separated
by SDS/PAGE and stained with Coomassie Blue to visualize
co-purified proteins. Protein bands present in the eluate of the
TssK–His6 strain, but not the wild-type strain (negative control,
encoding no His6-tagged proteins), were selected and subjected to
MS identification (Figure 5C). Three TssK–His6-specific bands
were identified as TssK itself (50 kDa) and as two other T6SS
core proteins, TssF (SMA2272; 71 kDa) and TssG (SMA2273,
41 kDa). Hence, in this native pull-down experiment, TssF and
TssG were isolated by virtue of their interaction with TssK.
Having identified TssF and TssG as TssK-specific binding
partners, we aimed to investigate further their role in Type VI
secretion and in subcomplex assembly. Analysis of their genomic
context revealed that TssF and TssG are encoded by overlapping
genes in a manner consistent with mutual interaction of the
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Figure 5 Isolation of a native TssK-containing complex
(A) Anti-TssK, anti-Hcp1 and anti-Ssp2 immunoblots of cellular or secreted proteins, as indicated, from wild-type S. marcescens Db10 (WT), a strain carrying an in-frame deletion of tssK (GE04,
tssK ) and strains encoding N-terminally His6-tagged TssK (SJC23; His6–tssK ) and C-terminally His6-tagged TssK (MJF1; tssK –His6) at the native chromosomal location. (B) Subcellular
localization of chromosomally encoded C-terminally His6-tagged TssK protein. The strain encoding His6-tagged TssK (MJF1; tssK –His6) was subjected to fractionation as described in the text (WC,
whole-cell extract; PP, periplasm; CYT, cytoplasm; MEM, membranes). Fractions were analysed by immunoblotting using antibodies against TssK, MBP (periplasmic marker), RNAPβ (cytoplasmic
marker) and TssJ (membrane marker) as indicated. (C) Identification of TssK-associated proteins by Ni2 + -affinity purification (pull-down assay). Inner membrane fractions were prepared from the
strain encoding chromosomal His6-tagged TssK (MJF1; tssK –His6), together with the wild-type (no His6 tag) as a negative control, and were incubated with magnetic Ni2 + beads to co-isolate
TssK–His6 with any bound proteins. Top: eluted proteins were resolved by SDS/PAGE (15 % gel) and visualized by colloidal Coomassie Blue staining. Black arrowheads indicate the positions of
three bands specifically isolated from the TssK–His6 sample; these bands were identified as TssK, TssF (SMA2272, predicted mass 70.8 kDa) and TssG (SMA2273, predicted mass 41.1 kDa), as
indicated, by MS. Bottom: anti-TssK immunoblot on the same pull-down samples. Molecular masses are indicated in kDa.
proteins and likely translational coupling (Figure 6A). Indeed
the genomic organization of TssF (COG3519) adjacent to TssG
(COG3520) is highly conserved across T6SS gene clusters
[51]. Strains carrying in-frame deletions of tssF and tssG were
constructed in the chromosomal tssK–His6 background. The T6SS
functionality of these new strains was tested and it was found that
deletion of tssF or tssG completely abolished secretion of Hcp1
and Ssp2 (Figures 6B and 6D). This confirmed that TssF and
TssG are essential components of the T6SS in S. marcescens. In
contrast, tssF and tssG deletions did not affect the membrane
localization of the native TssK protein (Figures 6C and 6E).
Affinity purifications of TssK–His6 from tssF or tssG mutants
failed to yield TssG or TssF respectively, suggesting that a pre-
formed TssFG complex may interact with TssK (results not
shown).
TssK, TssF and TssG form a large stable complex in vitro
To confirm the interaction of TssK with TssF and TssG identified
in vivo, we purified the corresponding complex in vitro. The
three proteins were co-expressed in E. coli and purified using
a cleavable N-terminal His6 tag on TssF. Following purification
by Ni2 + -based IMAC, cleavage of the His6 tag and reverse IMAC,
a complex containing the three proteins was analysed further by
SEC (Figure 7A). The identity of each band was confirmed by
MS and when the IMAC was repeated using a construct lacking
His6–TssF, TssG and TssK were not isolated (results not shown).
Hence this analysis confirmed the existence of a stable complex
of TssF, TssG and TssK and indicated further that the complex
contains multiple subunits, displaying an apparent molecular mass
of >670 kDa (i.e. greater than that of the largest standard protein
analysed on the column). To estimate the stoichiometry of each
protein within the complex, we performed quantitative in-gel
staining [47]. This gave a molar ratio of 4:2:1 TssK/TssF/TssG
(Figure 7B). Given that the apparent molecular mass of the
complex is far in excess of 385 kDa (4×TssK + 2×TssF + TssG),
we suggest that the stoichiometry of the complex could be 12:6:3
TssK/TssF/TssG, accommodating four trimers of TssK. Overall,
it is clear that the TssFGK complex represents a physiologically
relevant, stable and multisubunit subcomplex of the T6SS.
DISCUSSION
In the present paper, we report the functional and biochemical
characterization of one of the highly conserved proteins of the
T6SS: TssK. We have shown that TssK is required for secretion
of Hcp1 and Ssp2 and thus makes an essential contribution
to the function of the T6SS machinery in S. marcescens. In
agreement with this, TssK was found to be essential for the
formation of visible foci of TssB–sfGPF in EAEC, suggesting
that assembly of the T6SS could not proceed to incorporate
the TssBC-containing contractile sheath [43]. Our subcellular
localization of the native TssK protein found it to be associated
with the membrane fraction, specifically the inner membrane. This
is in agreement with the finding that TssK is present in the inner
membrane fraction of wild-type P. aeruginosa [52]. Our analysis
indicates that TssK is not an integral membrane protein, supported
further by the detection of TssK in the cytoplasmic fraction when
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Figure 6 TssF and TssG are essential components of the T6SS, but are not required for TssK localization to the membrane
(A) Schematic depiction of the genetic context of tssF and tssG illustrating their potential translational coupling. All of the genes in the S. marcescens Db10 T6SS gene cluster (SMA2244–2281)
are shown, with core conserved components shaded and lettered according to the Tss nomenclature. TssF residues are shown in green; TssG residues are shown in blue. The position of the TssG
ribosome-binding site (RBS) is underlined with a broken line; the TssF stop codon is shown as an asterisk. (B and D) TssG and TssF are required for Type VI secretion. Anti-Hcp1 immunoblot of
cellular and secreted proteins and anti-Ssp2 immunoblot of secreted proteins from strains bearing in-frame deletions of tssG (GE05; tssG,tssK –His6) (B) or tssF (GE06; tssF ,tssK –His6) (D),
compared with the parental strain with wild-type T6SS activity (MJF1; tssK –His6). (C and E) TssK localization is not affected by deletion of TssG or TssF. Strains encoding His6-tagged TssK in tssG
background (GE05; tssG,tssK –His6) (C) or tssF background (GE06; tssF ,tssK –His6) (E) were subjected to fractionation as described in the text (WC, whole-cell extract; PP, periplasm; CYT,
cytoplasm; MEM, membranes). Fractions were analysed by immunoblotting using antibodies against TssK, MBP (periplasmic marker), RNAPβ (cytoplasmic marker) and TssJ (membrane marker)
as indicated. Molecular masses are indicated in kDa.
overexpressed in EAEC [43]. Rather, our data suggest that it is
associated with the inner membrane by virtue of interactions with
other T6SS proteins, within a membrane-associated assembly
representing some or all of the T6SS apparatus. This complex is
clearly highly stable, since TssK association with the membrane
fraction cannot be abrogated by high salt, carbonate or detergent.
We speculate that detergent resistance could be either as a
result of the transmembrane protein domains of TssLM being
shielded from the detergent by other proteins in the complex,
or because the assembly is so large that it continues to
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Figure 7 TssK, TssF and TssG form a stable complex in vitro
(A) SEC profile of the complex formed between TssK, TssF and TssG. Separation was performed
using a calibrated Superose 6 10/300 GL column. The proteins had previously been co-expressed
in E. coli and the complex was initially purified by IMAC and negative IMAC, using a TEV
protease-cleavable N-terminal His6 tag on TssF. The theoretical mass of each protein is given
(kDa) and the complex has an apparent molecular mass of >670 kDa. (B) Analysis of the
complex-containing peak observed in SEC by quantitative in-gel SYPRO Orange staining.
Quantification of bound fluorescence gives a molar ratio of approximately 4:2:1 TssK/TssF/TssG.
sediment on ultracentrifugation even when released from the lipid
bilayer.
During initial structural and biochemical analyses of TssK, it
became apparent that recombinant TssK protein, purified from
the native T6SS-harbouring S. marcescens, exhibited striking
oligomerization properties. Stable trimeric, hexameric and higher-
order species were observed in solution. These results demonstrate
that TssK has a propensity to self-interact and suggest that it has
the ability to form large structures. The biological significance
of these large structures and the form, if any, that they take at
native levels in vivo are yet to be determined (see below). Our
attempts to crystallize TssK were unsuccessful. Its existence in
multiple oligomeric forms in solution (both when purified from
S. marcescens or E. coli; results not shown) probably explains
this lack of success. The recent study by Zoued et al. [43] is in
accord with our observation of a basic trimeric unit for TssK.
The authors observed that TssK from EAEC exists as a trimer in
solution, with EM and SAXS analyses suggesting that it displays
a ‘three-armed’ structure [43]. However, our work on TssK from
S. marcescens has demonstrated for the first time that TssK can
adopt an alternative, stable, hexameric state in solution and has
the potential to form higher-order oligomers, at least in vitro.
By utilizing a chromosomal epitope-tagging approach, where
the protein is expressed at normal levels in concert with all
of the other proteins of the system, a native TssK-containing
complex was isolated. This revealed, for the first time, that
TssK interacts with two other core conserved components, TssF
and TssG, forming a newly identified T6SS subcomplex. The
interaction of TssK–TssF–TssG was confirmed by the isolation of
a complex containing the three proteins in vitro. The maintenance
and detection of the interaction through a native-level affinity
purification, together with the isolation of a stable complex
in vitro, strongly suggests that the interactions are relatively
strong and a TssKFG complex is a physiologically relevant
composite part of the T6SS. The molar ratio of the three proteins
is 4:2:1 (TssK/TssF/TssG), which, together with the large size
of the complex, allows us to suggest a possible stoichiometry of
12:6:3 (TssK/TssF/TssG). However, although it would be clearly
predicted that these proteins will be in multiple copies, the
stoichiometry of TssK, TssF and TssG in vivo, within the entire
T6SS assembly, remains to be determined. TssF and TssG were
confirmed to represent essential components of the T6SS in S.
marcescens, in agreement with systematic mutagenesis studies in
E. tarda and V. cholerae showing that each is required for T6SS
function [41,42]. Our data also suggest that they interact with
each other, probably before interaction with TssK. Importantly,
TssF and TssG are not required for the recruitment of TssK to the
membrane fraction. This suggests that, during T6SS assembly,
a complex of TssLM, the only integral inner membrane proteins
within the T6SS, is in place first, anchoring the nascent machinery
to the inner membrane, with TssK and then TssFG recruited
subsequently (depicted in our proposed model, Figure 8). In
support of this idea, TssK has been reported to interact with TssL
[43]. Interestingly, none of TssJ, TssE or TssH is required for TssK
localization, therefore they may be recruited to the machinery in
the later stages of assembly. Indeed, there is already evidence that
TssH is recruited very late, since it associates with contracted
TssBC sheaths [39,53]. Hence all three proteins, i.e. TssK, TssF
and TssG, play an important role in the assembly of the T6SS
machine and form another T6SS subcomplex, in addition to, for
example, the TssJLM or TssBC subcomplexes.
The present study is the first to identify a TssK-containing
complex under native conditions, demonstrating that TssK stably
interacts with TssFG. The recent study in EAEC suggested that
TssK can interact with Hcp and TssC (tail tube and sheath),
TssL (membrane complex) and TssA (putative cytoplasmic/basal
component), by detection of bacterial two-hybrid interaction
or co-immunoprecipitation between pairs of proteins expressed
heterologously [43]. The TssK–Hcp interaction, with a Kd of
27 μM, was confirmed in vitro and suggests that TssK may be
involved in connecting the phage tail-like structure of the T6SS
with a basal complex. However, an interaction between TssK and
TssF or TssG was not detected using this plasmid-based approach.
Our data suggest that this is because TssK only interacts with
a TssFG complex and not with the individual proteins, either
because the complex itself is recognized and/or because TssF
and TssG are unstable in the absence of the other. Indeed, when
we attempted to purify TssF and TssG separately for binding
studies between these proteins and TssK, we were unable to
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Figure 8 Speculative model of the assembly of TssK, TssF and TssG into
the T6SS
The inner membrane components of the T6SS, TssL and TssM, are in place first, marking the
site of T6SS assembly and anchoring the complex to the inner membrane. TssK is subsequently
recruited to the assembly and becomes tethered to the membrane by interacting with TssLM,
either directly or through interactions with other basal components recruited ahead of it, for
example TssA. TssFG units are next recruited to the basal complex through their interaction with
TssK. Subsequently, other components of the machinery, including the Hcp tube, TssBC sheath
and TssH, are recruited. TssJ can join TssLM to complete the membrane subassembly at any
point, but this is not required for TssK recruitment. In the final T6SS assembly, TssKFG form a
subcomplex within the basal complex anchored to the cytoplasmic side of the inner membrane
which probably also contains TssA and TssE. This basal structure is connected to the membrane
complex, Hcp tube and the TssBC sheath, allowing contraction of the sheath to propel Hcp, VgrG
and secreted proteins out of the cell. TssK itself may be involved in mediating the interaction of
the Hcp tube with the basal complex and/or may contribute to the dynamic mechanism of the
system through a conformational change within the TssKFG subcomplex. Multimeric TssK is
shown in yellow and the TssFG complex in green; letters A–M represent TssA–TssM; IM, inner
membrane; OM, outer membrane.
overproduce TssG or to isolate soluble TssF (results not shown),
suggesting a mutual stability requirement and consistent with
putative translational coupling between the proteins (Figure 6A).
Our successful identification of the TssKFG complex illustrates
the value of identifying interactions at native protein levels, in the
native organism, where all components of the system are present
and in the correct stoichiometry. The fact we did not observe
TssL, TssC or Hcp in our native pull-downs may indicate that the
interactions of these proteins with TssK are too weak or transient
to survive the purification at detectable levels.
It has been observed by microscopy that the base of the
contractile TssB–TssC sheath-like structure is connected to
the inner membrane by a large cytoplasmic bell-shaped ‘basal’
structure that is yet to be fully characterized [36]. It is thought
that this large complex may represent an assembly platform
similar to the bacteriophage baseplate, a structure responsible for
contraction of the bacteriophage tail sheath and correct assembly
of the tail hub and tube [23,54]. It has been speculated that the
core T6SS components, i.e. TssA, TssE, TssF, TssG and TssK,
may form part of the T6SS cytoplasmic basal structure [55].
Indeed, TssE has been shown to display significant sequence
homology with bacteriophage T4 gp25, a structural component
of the baseplate, and is localized in the cytoplasm [34,40]. It
is thought that TssE, with other components of the T6SS basal
complex, might contribute to the assembly of the Hcp tube
and the TssB–TssC sheath structure [23]. However, no obvious
similarities or homologies were detected between TssF, TssG or
TssK and bacteriophage components at the sequence level [22].
The T6SS basal structure probably also includes, or interacts
with, the cytoplasmic domains of the inner membrane proteins
within the membrane complex, anchoring the machine to the
inner membrane. Consistent with TssK being part of such a
basal complex, native-level purification of TssK revealed for the
first time an interaction between this protein and two other core
components also predicted to reside in a cytoplasmic T6SS basal
complex, TssF and TssG. In bacteriophage T4, the baseplate is
composed of 16 different proteins and has six-fold symmetry
with a diameter of 52 nm around its base and a height of 27 nm
[54]. However, how similar a T6SS basal complex containing
TssKFG, and perhaps also TssA and/or TssE, actually is to the
phage baseplate remains to be determined.
The in vivo significance of the large EM-visible structures
formed by purified TssK, if any, is currently unclear. However,
the stability of the trimer and hexamer forms of recombinant
TssK indicates these forms are likely to exist in vivo. We propose
that post-translational modification of TssK or its interaction
with other T6SS proteins may trigger a ‘switch’ between these
different forms which may in turn mediate conformational
changes involved in the dynamic steps of Type VI secretion.
Of note, a minor ‘shoulder’ on the SEC profile of the TssKFG
complex (Figure 7B) may indicate the existence of a second form
of this TssK-containing complex. The ability of recombinant
TssK alone to further form tubular-like structures in vitro may
indicate a propensity to associate into ring-like structures. Thus,
if TssK does form part of the T6SS baseplate, it is likely to be
present in multiple copies and perhaps form rings. ‘Excessive’
polymerization of TssK may be limited in vivo by its interaction
with other components of the dynamic T6SS apparatus, perhaps
TssFG.
In conclusion, we have shown for the first time that the core
T6SS component TssK can exist in several stable oligomeric
states, provided evidence that it localizes at the inner membrane
in a manner consistent with its presence in a membrane-anchored
T6SS basal structure, and revealed that it interacts with TssF and
TssG complex at native levels to form a new subcomplex of the
system. Furthermore, our results and those of others, described
above, have allowed us to propose a model for the assembly
of TssK, TssF and TssG into the T6SS machinery (Figure 8).
It is clear that TssK represents a central component of the T6SS
machine. Thus it may represent a future target for the development
of antimicrobial therapies aimed at disrupting the T6SS and hence
disabling the many pathogenic bacteria which use T6SSs to attack
competitor bacteria or host cells.
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